SCHEMBL7310802

SCHEMBL7310802

COc1ccc(SC2CCCC2C(=O)NOC(C)(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
CTSK P43235 1/20 0.41
RAB9A P51151 5/20 0.38
NPC1 O15118 4/20 0.38
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MDM2 Q00987 1/20 0.38
SCN9A Q15858 1/20 0.38
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
STS P08842 1/20 0.35
TRIP13 Q15645 1/20 0.35
EPHX2 P34913 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7310798 1.00 MMP2 (0.41) MMP2MMP9CTSKRAB9ANPC1
SCHEMBL7305924 0.98 CTSK (0.43) MMP2MMP9CTSKRAB9ANPC1
SCHEMBL31630289 0.82 MMP2 (0.43) MMP2MMP9CTSKRAB9ANPC1
SCHEMBL7311871 0.80 SMN1; SMN2 (0.44) MMP2MMP9CTSKRAB9ANPC1
SCHEMBL7311882 0.80 SMN1; SMN2 (0.44) MMP2MMP9CTSKRAB9ANPC1
SCHEMBL7311878 0.80 SMN1; SMN2 (0.44) MMP2MMP9CTSKRAB9ANPC1
SCHEMBL7308764 0.78 SMN1; SMN2 (0.47) MMP2MMP9CTSKRAB9ANPC1
Anisole SCHEMBL7310806 0.76 SCN9A (0.42) MMP2MMP9RAB9ANPC1ALDH1A1
SCHEMBL7302689 0.75 MMP9 (0.74) MMP2MMP9SMN1; SMN2SCN9ASTS
SCHEMBL7302697 0.75 MMP9 (0.74) MMP2MMP9SMN1; SMN2SCN9ASTS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed